Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

A slew of pharma mergers and acquisitions in the first month of 2024 has continued with a $2.2 billion play by Sanofi for Inhibrx and its clinical-stage drug candidate for alpha-1 antitrypsin ...

Research has shown that occupational exposure to these substances can account for up to 20% of COPD cases worldwide. Some ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s stock price reached a new 52-week low on Wednesday . The stock traded as low as $11.34 and last traded at $11.66, with a volume of 3223027 ...

Overall, the life expectancy of patients with SCD is lower than that of persons without SCD. 1 However, life expectancy varies depending on the type of disease, treatments administered, and ...

After hours: December 30 at 5:17:20 PM EST Loading Chart for KRRO ...